Inhibitory effects of statins on human monocarboxylate transporter 4
Authors:
- Yukio OtsukaYOYukio Otsuka
- Shirou ItagakiSIShirou Itagaki
- Takeshi HiranoTHTakeshi Hirano
- Ken IsekiKIKen Iseki
- 1 July 2006
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 317 (1) , 19-25
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 22 references indexed in Scilit:
- Transport Mechanism for L-Lactic Acid in Human Myocytes Using Human Prototypic Embryonal Rhabdomyosarcoma Cell Line (RD Cells)Biological and Pharmaceutical Bulletin, 2005
- Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitorsBiochemical Pharmacology, 2004
- The SLC16 gene family?from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyondPflügers Archiv - European Journal of Physiology, 2003
- Myopathy and rhabdomyolysis with lipid-lowering drugsToxicology Letters, 2002
- Effects of HMG-CoA Reductase Inhibitors on Skeletal MuscleDrug Safety, 2002
- Blocking of Acidosis-Mediated Apoptosis by a Reduction of Lactate Dehydrogenase Activity through Antisense mRNA ExpressionBiochemical and Biophysical Research Communications, 2001
- MCT1-Mediated Transport of L-Lactic Acid at the Inner Blood–Retinal Barrier: A Possible Route for Delivery of Monocarboxylic Acid Drugs to the RetinaPharmaceutical Research, 2001
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Management of Primary HyperlipidemiaNew England Journal of Medicine, 1995
- Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol LevelsCirculation, 1995